Form4insider filings, from the source

SEC Form 4 · accession 0001225208-16-033428

Edwards Lifesciences Corp · EW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Huimin Wang
Officer — CVP, Japan & Intercontinental
Period of report
May 12, 2016
Accepted (ET)
May 16, 2016 · 7:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2May 12, 2016A1,475$0.00A69,305D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Acquire)F2,F3$105.59May 12, 2016A14,700AJun 12, 2016May 11, 2023Common Stock14,70014,700D
Performance RightsF4,F2—May 12, 2016A1,825A——Common Stock1,8251,825D

Explanation of responses